The diagnostic value and mechanistic role of miR-20b-5p in premature coronary artery disease
Irish Journal of Medical Science (1971 -) · 2026-10 · 195 (5) · 2687-2695
DOI: 10.1007/s11845-026-04443-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Irish Journal of Medical Science (1971 -), online erschienen am 18.05.2026. Verfasst von Shizhao Hou und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, 511400, China. Hauptthemen laut MEDLINE: MicroRNAs, Coronary Artery Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Guangdong Provincial Key Laboratory of Research on Emergency in TCM.
Abstract (Originalsprache)
BACKGROUND: Premature coronary artery disease (PCAD) is marked by accelerated progression of atherosclerosis, an increased incidence of adverse cardiovascular events, and a less favorable long-term prognosis. AIMS: The diagnostic potential and mechanistic basis of serum miR-20b-5p in PCAD. METHODS: Serum levels of miR-20b-5p, sd-LDL indicators (including particle number, concentration, proportion), and LDL particle diameter were measured. Logistic regression identified risk factors for coronary stenosis severity. Spearman analysis assessed the association between miR-20b-5p and Gensini score. ROC curve analysis evaluated clinical diagnostic utility of miR-20b-5p. Cell experiments validated the regulatory interaction between miR-20b-5p and CCL1, and their effects on oxidative stress and inflammation. RESULTS: The sd-LDL index and miR-20b-5p levels were significantly altered in patients with PCAD. Furthermore, miR-20b-5p levels and sd-LDL particle count were also associated with the severity of coronary stenosis.Serum levels of miR-20b-5p showed a significant negative correlation with the Gensini score and could serve as a diagnostic biomarker. miR-20b-5p directly targeted and inhibited CCL1, and its overexpression attenuated ox-LDL-induced oxidative stress and inflammatory reactions in HCAECs. CONCLUSIONS: miR-20b-5p and abnormal small dense low-density lipoprotein are risk factors for evaluating the severity of coronary artery stenosis. Moreover, miR-20b-5p may alleviate vascular endothelial oxidative stress and inflammation by targeting CCL1, making it a potential therapeutic target for early intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, 511400, China.
- Geriatric Medicine Department, Shenzhen Luohu District Traditional Chinese Medicine Hospital, Shenzhen, 518001, China.
- Department of Coronary Heart Disease III, Cangzhou Central Hospital, Cangzhou, 061001, China.
- Department of Cardiology, Suzhou Municipal Hospital ,The Affiliated Suzhou Hospital of Nanjing Medical University, 80 Tian'erdang Road, Wuzhong District, Suzhou, Jiangsu, 215104, China. weilidr1@163.com.
Förderung
- Guangdong Provincial Key Laboratory of Research on Emergency in TCM
Zitieren
APA
Hou, S., Liu, A., Sun, R., Zhan, G., Zhang, W., Guo, Z., Zhao, M., Jia, G., & Li, W. (2026). The diagnostic value and mechanistic role of miR-20b-5p in premature coronary artery disease. Irish Journal of Medical Science (1971 -), 195(5), 2687-2695. https://doi.org/10.1007/s11845-026-04443-7
Vancouver
Hou S, Liu A, Sun R, Zhan G, Zhang W, Guo Z, et al. The diagnostic value and mechanistic role of miR-20b-5p in premature coronary artery disease. Irish Journal of Medical Science (1971 -). 2026;195(5):2687-2695. doi:10.1007/s11845-026-04443-7
BibTeX
@article{Hou2026,
author = {Hou, Shizhao and Liu, Ao and Sun, Rongguo and Zhan, Guangli and Zhang, Wei and Guo, Zhihao and Zhao, Ming and Jia, Guowei and Li, Wei},
title = {The diagnostic value and mechanistic role of miR-20b-5p in premature coronary artery disease},
journal = {Irish Journal of Medical Science (1971 -)},
year = {2026},
volume = {195},
number = {5},
pages = {2687--2695},
doi = {10.1007/s11845-026-04443-7}
}
EUVIMED